Carlos Manuel Buesa Arjol
Chief Executive Officer chez ORYZON GENOMICS S.A.
Fortune : 7 M $ au 31/03/2024
Profil
Carlos Manuel Buesa Arjol is the founder.
He founded Oryzon Genomics SA in 2000 and currently serves as the Chairman, President & Chief Executive Officer.
Dr. Buesa Arjol is also currently working as a Director at Oncnosis Pharma AIE, Orycamb Project Aie, Asociacion De Empresas Biotecnologicas, Ninfas Aie, Geadig-Pharma Aie, and as a Partner at Mendelion Lifesciences SL.
In the past, Dr. Buesa Arjol worked as a Director at Palobiofarma SL and Neurotec Pharma SL.
From 2008 to 2021, Dr. Buesa Arjol served as a Director at Inveready Seed Capital SCR SA. Additionally, Dr. Buesa Arjol was the President of l'Associació Catalana d'Empreses de Biotecnologia.
Dr. Buesa Arjol holds a doctorate degree from the University of Barcelona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORYZON GENOMICS SA
5,74% | 31/12/2022 | 3 558 903 ( 5,74% ) | 7 M $ | 31/03/2024 |
Postes actifs de Carlos Manuel Buesa Arjol
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Chief Executive Officer | 02/06/2000 |
Asociacion De Empresas Biotecnologicas
 Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Director/Board Member | - |
| Oncnosis Pharma AIE | Director/Board Member | - |
Orycamb Project Aie
 Orycamb Project Aie Construction MaterialsNon-Energy Minerals Orycamb Project Aie is a Spanish company that engages in the mining of gravel and sandpits. The private company is based in Tarragona, Spain. | Director/Board Member | - |
| Ninfas Aie | Director/Board Member | - |
| Geadig-Pharma Aie | Director/Board Member | - |
Mendelion Lifesciences SL
 Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Corporate Officer/Principal | - |
Anciens postes connus de Carlos Manuel Buesa Arjol
| Sociétés | Poste | Fin |
|---|---|---|
Inveready Seed Capital SCR SA
 Inveready Seed Capital SCR SA Investment ManagersFinance Inveready Seed Capital SCR SA fund invests in the early years of technology-oriented companies. Specifically, this fund focuses on the seed stage. The fund will invest between €100,000 and €500,000 for a minority stake in the invested company. | Director/Board Member | 01/06/2021 |
Neurotec Pharma SL
 Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Director/Board Member | 27/11/2015 |
| ░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Carlos Manuel Buesa Arjol
| University of Barcelona | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Inveready Seed Capital SCR SA
Inveready Seed Capital SCR SA Investment ManagersFinance Inveready Seed Capital SCR SA fund invests in the early years of technology-oriented companies. Specifically, this fund focuses on the seed stage. The fund will invest between €100,000 and €500,000 for a minority stake in the invested company. | Finance |
Palobiofarma SL
 Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | Health Technology |
Neurotec Pharma SL
Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Health Technology |
| Oncnosis Pharma AIE | |
l'Associació Catalana d'Empreses de Biotecnologia
 l'Associació Catalana d'Empreses de Biotecnologia Miscellaneous Commercial ServicesCommercial Services l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain. | Commercial Services |
Orycamb Project Aie
Orycamb Project Aie Construction MaterialsNon-Energy Minerals Orycamb Project Aie is a Spanish company that engages in the mining of gravel and sandpits. The private company is based in Tarragona, Spain. | Non-Energy Minerals |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Industrial Services |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Health Technology |
| Ninfas Aie | |
| Geadig-Pharma Aie |
